Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C28H29N5O3 |
Molecular Weight | 483.5616 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@H](CN(C(=O)C1=CC=C(C=C1)C#N)C2=CC=CC=N2)N3CCN(CC3)C4=C5OCCOC5=CC=C4
InChI
InChIKey=NRPQELCNMADTOZ-OAQYLSRUSA-N
InChI=1S/C28H29N5O3/c1-21(31-13-15-32(16-14-31)24-5-4-6-25-27(24)36-18-17-35-25)20-33(26-7-2-3-12-30-26)28(34)23-10-8-22(19-29)9-11-23/h2-12,21H,13-18,20H2,1H3/t21-/m1/s1
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Synthesis and biological evaluation of benzodioxanylpiperazine derivatives as potent serotonin 5-HT(1A) antagonists: the discovery of Lecozotan. | 2005 May 19 |
|
Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties. | 2005 Sep |
|
Progress update: Pharmacological treatment of Alzheimer's disease. | 2007 |
|
A positron emission tomography study to assess binding of lecozotan, a novel 5-hydroxytryptamine-1A silent antagonist, to brain 5-HT1A receptors in healthy young and elderly subjects, and in patients with Alzheimer's disease. | 2008 Jan |
|
Bilobalide modulates serotonin-controlled behaviors in the nematode Caenorhabditis elegans. | 2009 Jun 22 |
|
Safety, tolerability, pharmacokinetics and pharmacodynamics of ascending single and multiple doses of lecozotan in healthy young and elderly subjects. | 2009 Mar |
|
Drug development for Alzheimer's disease: recent progress. | 2010 Dec |
|
Acute lecozotan administration increases learning and memory in rats without affecting anxiety or behavioral depression. | 2010 May |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C66885
Created by
admin on Fri Dec 15 15:39:10 GMT 2023 , Edited by admin on Fri Dec 15 15:39:10 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
10116877
Created by
admin on Fri Dec 15 15:39:10 GMT 2023 , Edited by admin on Fri Dec 15 15:39:10 GMT 2023
|
PRIMARY | |||
|
100000126191
Created by
admin on Fri Dec 15 15:39:10 GMT 2023 , Edited by admin on Fri Dec 15 15:39:10 GMT 2023
|
PRIMARY | |||
|
48854OTZ5E
Created by
admin on Fri Dec 15 15:39:10 GMT 2023 , Edited by admin on Fri Dec 15 15:39:10 GMT 2023
|
PRIMARY | |||
|
434283-16-6
Created by
admin on Fri Dec 15 15:39:10 GMT 2023 , Edited by admin on Fri Dec 15 15:39:10 GMT 2023
|
PRIMARY | |||
|
C500836
Created by
admin on Fri Dec 15 15:39:10 GMT 2023 , Edited by admin on Fri Dec 15 15:39:10 GMT 2023
|
PRIMARY | |||
|
LECOZOTAN
Created by
admin on Fri Dec 15 15:39:10 GMT 2023 , Edited by admin on Fri Dec 15 15:39:10 GMT 2023
|
PRIMARY | |||
|
CHEMBL372205
Created by
admin on Fri Dec 15 15:39:10 GMT 2023 , Edited by admin on Fri Dec 15 15:39:10 GMT 2023
|
PRIMARY | |||
|
SUB33289
Created by
admin on Fri Dec 15 15:39:10 GMT 2023 , Edited by admin on Fri Dec 15 15:39:10 GMT 2023
|
PRIMARY | |||
|
8489
Created by
admin on Fri Dec 15 15:39:10 GMT 2023 , Edited by admin on Fri Dec 15 15:39:10 GMT 2023
|
PRIMARY | |||
|
DTXSID30870354
Created by
admin on Fri Dec 15 15:39:10 GMT 2023 , Edited by admin on Fri Dec 15 15:39:10 GMT 2023
|
PRIMARY | |||
|
C74394
Created by
admin on Fri Dec 15 15:39:10 GMT 2023 , Edited by admin on Fri Dec 15 15:39:10 GMT 2023
|
PRIMARY | |||
|
DB12540
Created by
admin on Fri Dec 15 15:39:10 GMT 2023 , Edited by admin on Fri Dec 15 15:39:10 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)